About
Astellas Pharma appears at No. 776 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Tokyo, Japan and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $14.2B in sales, $1.9B in profit, $22.4B in assets and a market value of $26.3B.